Restatement Of Condensed Consolidated Financial Statements (Condensed Consolidated Statements Of Cash Flow) (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities of continuing operations
Net income / (loss)	$ 363,238	$ 1,325,620	$ 150,929
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:
Net (income) / loss from discontinued operations	0	0	8,405
Depreciation and amortization	20,377	19,718	16,947
Deferred income taxes	(3,605)	39,042	(27,944)
Unrealized foreign exchange (gains) / losses	(93,772)	138,845	(2,911)
Cost of debt extinguishment	0	0	14,114
Stock options fair value expense	2,953	2,605	3,206
Dividends received	0	0	10,859
Equity (income)/loss in affiliates	0	7,946	(13,386)
Gain on fair value remeasurement of previously held equity interest	0	(7,898)	0
Impairment charge	372,899	1,057,819	131,849
Impairments related to assets held for sale	675	7,355	0
Other non cash items	8,191	4,345	25,343
Changes in operating assets and liabilities:
Accounts receivable	82,651	74,606	25,399
Inventories	(46,155)	(7,413)	(4,024)
Prepayments and other current assets	(51,821)	(2,357)	1,966
Trade accounts payable	(32,526)	16,519	(16,874)
Other accrued liabilities and payables	4,419	4,474	(50,137)
Net cash provided by / (used in) operating activities from continuing operations	(98,952)	29,986	(28,117)
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(9,374)	(15,094)	(6,194)
Proceeds from the disposal of fixed assets	659	511	0
Purchase of intangibles (licenses)	0	(693)	0
Purchase of trademarks	0	(17,473)	(6,000)
Changes in restricted cash	0	0	481,419
Disposal of subsidiaries	0	0	124,160
Acquisitions of subsidiaries, net of cash acquired	0	(24,124)	(128,464)
Net cash provided by / (used in) investing activities from continuing operations	(8,715)	(56,873)	464,921
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility	122,803	57,512	63,853
Payment of bank loans, overdraft facility and other borrowings	(77,652)	(47,417)	(174,251)
Payment of long-term borrowings	0	0	(19,098)
Net borrowings of Senior Secured Notes	0	0	67,561
Payment of Senior Secured Notes	0	0	(367,954)
Decrease in short term capital leases payable	(566)	(76)	(501)
Options exercised	0	72	3,550
Net cash (used in) / provided by financing activities from continuing operations	93,225	10,091	(426,840)
Cash flows from discontinued operations
Net cash provided by / (used in) operating activities of discontinued operations	0	0	2,806
Net cash (used in) investing activities of discontinued operations	0	0	(330)
Net cash provided by / (used in) financing activities of discontinued operations	0	0	100
Net cash provided by/(used in) discontinued operations	0	0	2,576
Adjustment to reconcile the change in cash balances of discontinued operations	0	0	(2,576)
Currency effect on brought forward cash balances	4,761	(10,910)	(14,287)
Net increase / (decrease) in cash	(9,681)	(27,706)	(4,323)
Cash and cash equivalents at beginning of period	94,410	122,116	126,439
Cash and cash equivalents at end of period	84,729	94,410	122,116
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	0	23,174	41,344
Supplemental disclosures of cash flow information
Interest paid	101,633	103,836	111,535
Income tax paid	5,750	5,139	29,544
As previously reported
Cash flows from operating activities of continuing operations
Net income / (loss)		(1,323,384)	(138,073)
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:
Net (income) / loss from discontinued operations			8,405
Depreciation and amortization		19,718	16,947
Deferred income taxes		36,806	(40,800)
Unrealized foreign exchange (gains) / losses		138,845	(2,911)
Cost of debt extinguishment			14,114
Stock options fair value expense		2,605	3,206
Dividends received			10,859
Equity (income)/loss in affiliates		7,946	(13,386)
Gain on fair value remeasurement of previously held equity interest		(7,898)
Impairment charge		1,057,819	131,849
Impairments related to assets held for sale		7,355
Other non cash items		4,345	25,343
Changes in operating assets and liabilities:
Accounts receivable		74,606	25,399
Inventories		(7,413)	(4,024)
Prepayments and other current assets		(2,357)	1,966
Trade accounts payable		16,519	(16,874)
Other accrued liabilities and payables		4,474	(50,137)
Net cash provided by / (used in) operating activities from continuing operations		29,986	(28,117)
Cash flows from investing activities of continuing operations
Purchase of fixed assets		(15,094)	(6,194)
Proceeds from the disposal of fixed assets		511
Purchase of intangibles (licenses)		(693)
Purchase of trademarks		(17,473)	(6,000)
Changes in restricted cash			481,419
Disposal of subsidiaries			124,160
Acquisitions of subsidiaries, net of cash acquired		(24,124)	(128,464)
Net cash provided by / (used in) investing activities from continuing operations		(56,873)	464,921
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility		57,512	63,853
Payment of bank loans, overdraft facility and other borrowings		(47,417)	(174,251)
Payment of long-term borrowings			(19,098)
Net borrowings of Senior Secured Notes			67,561
Payment of Senior Secured Notes			(367,954)
Decrease in short term capital leases payable		(76)	(501)
Increase in short term capital leases payable			0
Transactions with equity holders			0
Options exercised		72	3,550
Net cash (used in) / provided by financing activities from continuing operations		10,091	(426,840)
Cash flows from discontinued operations
Net cash provided by / (used in) operating activities of discontinued operations			2,806
Net cash (used in) investing activities of discontinued operations			(330)
Net cash provided by / (used in) financing activities of discontinued operations			100
Net cash provided by/(used in) discontinued operations			2,576
Adjustment to reconcile the change in cash balances of discontinued operations			(2,576)
Currency effect on brought forward cash balances		(10,910)	(14,287)
Net increase / (decrease) in cash		(27,706)	(4,323)
Cash and cash equivalents at beginning of period		122,116	126,439
Cash and cash equivalents at end of period		94,410	122,116
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		23,174	41,344
Supplemental disclosures of cash flow information
Interest paid		103,836	111,535
Income tax paid		5,139	29,544
Adjustment
Cash flows from operating activities of continuing operations
Net income / (loss)		(2,236)	(12,856)
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:
Net (income) / loss from discontinued operations			0
Depreciation and amortization		0	0
Deferred income taxes		2,236	12,856
Unrealized foreign exchange (gains) / losses		0	0
Cost of debt extinguishment			0
Stock options fair value expense		0	0
Dividends received			0
Equity (income)/loss in affiliates		0	0
Gain on fair value remeasurement of previously held equity interest		0
Impairment charge		0	0
Impairments related to assets held for sale		0
Other non cash items		0	0
Changes in operating assets and liabilities:
Accounts receivable		0	0
Inventories		0	0
Prepayments and other current assets		0	0
Trade accounts payable		0	0
Other accrued liabilities and payables		0	0
Net cash provided by / (used in) operating activities from continuing operations		0	0
Cash flows from investing activities of continuing operations
Purchase of fixed assets		0	0
Proceeds from the disposal of fixed assets		0
Purchase of intangibles (licenses)		0
Purchase of trademarks		0	0
Changes in restricted cash			0
Disposal of subsidiaries			0
Acquisitions of subsidiaries, net of cash acquired		0	0
Net cash provided by / (used in) investing activities from continuing operations		0	0
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility		0	0
Payment of bank loans, overdraft facility and other borrowings		0	0
Payment of long-term borrowings			0
Net borrowings of Senior Secured Notes			0
Payment of Senior Secured Notes			0
Decrease in short term capital leases payable		0	0
Increase in short term capital leases payable			0
Transactions with equity holders			0
Options exercised		0	0
Net cash (used in) / provided by financing activities from continuing operations		0	0
Cash flows from discontinued operations
Net cash provided by / (used in) operating activities of discontinued operations			0
Net cash (used in) investing activities of discontinued operations			0
Net cash provided by / (used in) financing activities of discontinued operations			0
Net cash provided by/(used in) discontinued operations			0
Adjustment to reconcile the change in cash balances of discontinued operations			0
Currency effect on brought forward cash balances		0	0
Net increase / (decrease) in cash		0	0
Cash and cash equivalents at beginning of period		0	0
Cash and cash equivalents at end of period		0	0
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		0	0
Supplemental disclosures of cash flow information
Interest paid		0	0
Income tax paid		0	0
Restated
Cash flows from operating activities of continuing operations
Net income / (loss)		(1,325,620)	(150,929)
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:
Net (income) / loss from discontinued operations			8,405
Depreciation and amortization		19,718	16,947
Deferred income taxes		39,042	(27,944)
Unrealized foreign exchange (gains) / losses		138,845	(2,911)
Cost of debt extinguishment			14,114
Stock options fair value expense		2,605	3,206
Dividends received			10,859
Equity (income)/loss in affiliates		7,946	(13,386)
Gain on fair value remeasurement of previously held equity interest		(7,898)
Impairment charge		1,057,819	131,849
Impairments related to assets held for sale		7,355
Other non cash items		4,345	25,343
Changes in operating assets and liabilities:
Accounts receivable		74,606	25,399
Inventories		(7,413)	(4,024)
Prepayments and other current assets		(2,357)	1,966
Trade accounts payable		16,519	(16,874)
Other accrued liabilities and payables		4,474	(50,137)
Net cash provided by / (used in) operating activities from continuing operations		29,986	(28,117)
Cash flows from investing activities of continuing operations
Purchase of fixed assets		(15,094)	(6,194)
Proceeds from the disposal of fixed assets		511
Purchase of intangibles (licenses)		(693)
Purchase of trademarks		(17,473)	(6,000)
Changes in restricted cash			481,419
Disposal of subsidiaries			124,160
Acquisitions of subsidiaries, net of cash acquired		(24,124)	(128,464)
Net cash provided by / (used in) investing activities from continuing operations		(56,873)	464,921
Cash flows from financing activities of continuing operations
Borrowings on bank loans and overdraft facility		57,512	63,853
Payment of bank loans, overdraft facility and other borrowings		(47,417)	(174,251)
Payment of long-term borrowings			(19,098)
Net borrowings of Senior Secured Notes			67,561
Payment of Senior Secured Notes			(367,954)
Decrease in short term capital leases payable		(76)	(501)
Increase in short term capital leases payable			0
Transactions with equity holders			0
Options exercised		72	3,550
Net cash (used in) / provided by financing activities from continuing operations		10,091	(426,840)
Cash flows from discontinued operations
Net cash provided by / (used in) operating activities of discontinued operations			2,806
Net cash (used in) investing activities of discontinued operations			(330)
Net cash provided by / (used in) financing activities of discontinued operations			100
Net cash provided by/(used in) discontinued operations			2,576
Adjustment to reconcile the change in cash balances of discontinued operations			(2,576)
Currency effect on brought forward cash balances		(10,910)	(14,287)
Net increase / (decrease) in cash		(27,706)	(4,323)
Cash and cash equivalents at beginning of period		122,116	126,439
Cash and cash equivalents at end of period		94,410	122,116
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		23,174	41,344
Supplemental disclosures of cash flow information
Interest paid		103,836	111,535
Income tax paid		$ 5,139	$ 29,544